U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06849778) titled 'An Open-label Pharmacokinetic Study of TS-172 in Patients on Hemodialysis' on Feb. 16.
Brief Summary: A phase 1, open-label, pharmacokinetic study of TS-172 in patients on hemodialysis
Study Start Date: March 17
Study Type: INTERVENTIONAL
Condition:
Patients on Hemodialysis
Intervention:
DRUG: TS-172
oral administration of TS-172 20 mg
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Taisho Pharmaceutical Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....